Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic “LIF” Into the Brain: Preclinical Proof of Concept
Multiple sclerosis (MS) is a demyelinating autoimmune disease that attacks the brain, with year-on-year loss of brain volume, starting late teens and becoming manifest late twenties. There is no cure, and current therapies are immunosuppressive only. LIF is a vital stem cell growth factor active thr...
| Main Authors: | Raul de la Flor, Janette Robertson, Rostislav V. Shevchenko, Mo Alavijeh, Sean Bickerton, Tarek Fahmy, Su M. Metcalfe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-04-01
|
| Series: | Frontiers in Medical Technology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmedt.2021.640569/full |
Similar Items
-
Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice
by: Amy E. Wright, et al.
Published: (2024-03-01) -
动态监测LIF、β-hCG 及P水平对诊断输卵管妊娠的探讨
Published: (2008-01-01) -
Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson’s disease
by: Jing-Wei Zhao, et al.
Published: (2014-10-01) -
Photoluminescence of gamma-, proton- and alpha-irradiated LiF detectors
by: Marczewska Barbara, et al.
Published: (2012-08-01) -
Molecular dynamics simulations reveal key roles of the LIF receptor in the assembly of human LIF signaling complex
by: Bo Gao, et al.
Published: (2025-01-01)